11 analysts have expressed a variety of opinions on Allstate ALL over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 3 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 4 | 1 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 2 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $166.73, a high estimate of $193.00, and a low estimate of $140.00. Surpassing the previous average price target of $142.67, the current average has increased by 16.86%.
Analyzing Analyst Ratings: A Detailed Breakdown
A comprehensive examination of how financial experts perceive Allstate is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Jimmy Bhullar | JP Morgan | Raises | Overweight | $172.00 | $164.00 |
| C. Gregory Peters | Raymond James | Raises | Strong Buy | $180.00 | $155.00 |
| Michael Zaremski | BMO Capital | Raises | Market Perform | $158.00 | $140.00 |
| Brian Meredith | UBS | Raises | Buy | $171.00 | $160.00 |
| Andrew Kligerman | TD Cowen | Announces | Outperform | $193.00 | - |
| Alex Scott | Goldman Sachs | Raises | Buy | $164.00 | $141.00 |
| Yaron Kinar | Jefferies | Raises | Buy | $180.00 | $130.00 |
| Michael Phillips | Morgan Stanley | Raises | Overweight | $171.00 | $117.00 |
| Vikram Gandhi | HSBC | Announces | Hold | $145.00 | - |
| Michael Zaremski | BMO Capital | Raises | Market Perform | $140.00 | $125.00 |
| Brian Meredith | UBS | Raises | Buy | $160.00 | $152.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Allstate. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Allstate compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Allstate's stock. This comparison reveals trends in analysts' expectations over time.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Allstate's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Allstate analyst ratings.
All You Need to Know About Allstate
Allstate is one of the largest U.S. property and casualty insurers in the U.S. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 company agencies.
Unraveling the Financial Story of Allstate
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, Allstate showcased positive performance, achieving a revenue growth rate of 9.76% as of 30 September, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -0.28%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Allstate's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -0.31%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Allstate's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.04%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.63, caution is advised due to increased financial risk.
The Core of Analyst Ratings: What Every Investor Should Know
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
